Clinical Roundup UNC study: Accurate diagnostic mammography outcomes vary by racial and ethnic groups June 17, 2022Vol.48 No.24
Guest Editorial ASCO’s “rock concert” moments came 17 years apart—in 2005 and 2022DESTINY-04 results extend HER2-targeted therapy to a larger population in breast cancer June 10, 2022Vol.48 No.23By George W. Sledge Jr.
Clinical Roundup Lasofoxifene + abemaciclib shows potential in ER+/HER2− breast cancer with ESR1 mutation June 03, 2022Vol.48 No.22
Drugs & Targets FDA grants marketing authorization to Parsortix System for liquid biopsy in MBC May 27, 2022Vol.48 No.21
Clinical Roundup Racial and ethnic disparities persist for early-stage breast cancer detection and survival May 06, 2022Vol.48 No.18
In Brief Vera Bradley Foundation for Breast Cancer makes $12.5M commitment to IU School of Medicine April 22, 2022Vol.48 No.16
Clinical Roundup AURORA study identifies molecular features tied to breast cancer tumor spread April 15, 2022Vol.48 No.15
Drugs & Targets FDA fast tracks targeted breast cancer immunotherapy Bria-IMT April 15, 2022Vol.48 No.15
